Oncopeptides AB (ONCO) — Cash Flow Reinvestment Rate
Latest as of June 2024:
0.00x
Oncopeptides AB (ONCO) has a Cash Flow Reinvestment Rate of 0.00x as of June 2024, reinvesting Skr0.00 (capex Skr0.00 ) from operating cash flow of Skr8.77 Million. See ONCO net asset quality score to measure how much of total assets are equity-financed.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
Skr0.00
Capex + Investments
Operating Cash Flow
Skr8.77 Million
SEK
Capital Expenditures
Skr0.00
SEK
Annual Cash Flow Reinvestment Rate for Oncopeptides AB (None–None)
Year-by-year capital reinvestment analysis for Oncopeptides AB. For live market cap and broader valuation context, see market value of Oncopeptides AB.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow